Medical Condition News

RSS

Inspiration commences enrollment in second OBI-1 Accur8 clinical trial program for congenital hemophilia A

Inspiration Biopharmaceuticals, Inc. today announced the initiation of patient enrollment in the second of two pivotal studies in the Company's OBI-1 Accur8 clinical trial program.

28 Nov 2011

FDA grants Perrigo final approval for Guaifenesin Extended-Release Tablets ANDA

Perrigo Company today announced that it received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Guaifenesin Extended-Release Tablets, 600 mg.

28 Nov 2011

Bayer, Regeneron commence EYLEA Phase 3 clinical trial for wet AMD in China

Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that they have initiated a Phase 3 clinical trial evaluating the efficacy and safety of EYLEA (aflibercept) Injection in the neovascular form of age-related macular degeneration (wet AMD) in China.

28 Nov 2011

Henry Schein launches new integrated comprehensive solution to treat sleep apnea

Henry Schein, Inc., the largest provider of health care products and services to office-based practitioners, today announced the launch of its Sleep Complete™ program, a new integrated comprehensive solution that provides all of the information and products necessary for the successful implementation of dental sleep medicine into the dental practice.

28 Nov 2011

Micromet commences blinatumomab phase 2 trial for r/r B-precursor acute lymphoblastic leukemia

Micromet, Inc. today announced that it has initiated a phase 2 trial of its lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory (r/r) B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE® antibodies, designed to harness the body's T cells to kill cancer cells.

28 Nov 2011

Exelixis and NCI's CTEP enter CRADA to further evaluate cabozantinib

Exelixis, Inc. today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute's Cancer Therapy Evaluation Program (CTEP) for further evaluation of cabozantinib, Exelixis' lead compound, in a variety of solid tumors.

28 Nov 2011

New protein involved in defense mechanism against cancer

Researchers of the Swedish medical university Karolinska Institutet and the University of Cologne, Germany, have identified a new protein involved in a defense mechanism against cancer.

28 Nov 2011

Inspiration initiates second OBI-1 phase III clinical trial in congenital hemophilia A with inhibitors

Ipsen today announced that its partner Inspiration Biopharmaceuticals, Inc. has initiated the treatment of the first patient in the second of two pivotal studies from the OBI-1's Accur8 clinical trial program.

28 Nov 2011

A very low calorie diet can effectively cure type 2 diabetes mellitus

A low-calorie diet eliminates insulin dependence and leads to improved heart function in obese patients with type 2 diabetes, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

28 Nov 2011

3-D modeling combined with medical imaging provides new hope for serious facial injuries

By combining conventional medical imaging with some of the same 3-D modeling techniques used in Hollywood blockbusters, researchers are offering new hope to victims of serious facial injuries. Results of a new study on human face transplantation, led by Darren M. Smith, M.D., plastic surgery resident at the University of Pittsburgh Medical Center (UPMC), were presented today at the annual meeting of the Radiological Society of North America (RSNA).

28 Nov 2011

Novel proteomics based method detects inhibition of intracellular deubiquitylating enzymes

Researchers at the University of Oxford and Progenra, Inc. are pleased to announce the publication of a research article entitled "Activity-Based Chemical Proteomics Accelerates Inhibitor Development for Deubiquitylating Enzymes" that details a novel proteomics based method to detect inhibition of intracellular deubiquitylating enzymes (DUBs).

28 Nov 2011

Rare syndrome's workings could help explain how brain wiring goes awry

Potential clues to how autism miswires the brain are emerging from a study of a rare, purely genetic form of the disorders that affects fewer than 20 people worldwide. Using cutting-edge "disease-in a-dish" technology, researchers funded by the National Institutes of Health have grown patients' skin cells into neurons to discover what goes wrong in the brain in Timothy Syndrome.

28 Nov 2011

Most people with Timothy syndrome mutation have autistic symptoms

Neuroscientists at Stanford University School of Medicine have homed in on potential differences in autistic people's brain cells by studying brainlike spheres grown in an elaborate process from skin cells.

28 Nov 2011

Laminar air flow therapy via novel device could be beneficial for asthmatics: Study

A new device that offers drug-free bedside filtered air flow can significantly reduce patients' symptoms such as wheezing and tight chests in asthmatics. The temperature controlled laminar airflow treatment, called Protexo, filters out airborne triggers such as dust particles and mites, pet hairs and powders that cause irritation and inflammation of the lungs.

27 Nov 2011

Migraines and depression risk: Study finds link

According to a new Canadian study, people who get attacks of migraine may be at a higher risk for developing clinical depression.

27 Nov 2011

Moleac launches NurAiD II in France and Belgium

Biopharmaceutical Company Moleac has announced the launch in France and Belgium of NurAiD II. NurAiD II is a natural health supplement engineered to stimulate neuroplasticity and recovery.

25 Nov 2011

Transplantation of new neurons into damaged area of the brain could restore brain functions

Without neurons reacting to the blood leptin level, the brain does not control the feeling of hunger and fullness. This type of genetic defects results in severe obesity in humans and animals.

25 Nov 2011

Immunicum receives Swedish approval to commence first clinical trial of patented cancer vaccine

Immunicum, which is developing cancer vaccines, has received approval from the Swedish Medical Products Agency to start its first clinical trial. The study will be conducted on kidney cancer patients at the University Hospital in Uppsala. At the same time, the company secures substantial financing to complete the clinical trial.

25 Nov 2011

Cameras in the form of a pill

Cameras ingested in the form of a pill make it possible to examine areas of the stomach and intestines that cannot be reached using traditional equipment. Norwegian researchers are busy developing the next-generation camera pill.

25 Nov 2011

Even normal salt intake can cause hypertension in people suffering from sodium dysregulation

Hypertension is an endemic condition with far-reaching consequences. For instance, high blood pressure is the main cause of heart attacks and strokes. Other organs are also damaged by the chronic condition.

25 Nov 2011

Medical Condition News

Inspiration commences enrollment in second OBI-1 Accur8 clinical trial program for congenital hemophilia A

FDA grants Perrigo final approval for Guaifenesin Extended-Release Tablets ANDA

Bayer, Regeneron commence EYLEA Phase 3 clinical trial for wet AMD in China

Henry Schein launches new integrated comprehensive solution to treat sleep apnea

Micromet commences blinatumomab phase 2 trial for r/r B-precursor acute lymphoblastic leukemia

Exelixis and NCI's CTEP enter CRADA to further evaluate cabozantinib

New protein involved in defense mechanism against cancer

Inspiration initiates second OBI-1 phase III clinical trial in congenital hemophilia A with inhibitors

A very low calorie diet can effectively cure type 2 diabetes mellitus

3-D modeling combined with medical imaging provides new hope for serious facial injuries

Novel proteomics based method detects inhibition of intracellular deubiquitylating enzymes

Rare syndrome's workings could help explain how brain wiring goes awry

Most people with Timothy syndrome mutation have autistic symptoms

Laminar air flow therapy via novel device could be beneficial for asthmatics: Study

Migraines and depression risk: Study finds link

Moleac launches NurAiD II in France and Belgium

Transplantation of new neurons into damaged area of the brain could restore brain functions

Immunicum receives Swedish approval to commence first clinical trial of patented cancer vaccine

Cameras in the form of a pill

Even normal salt intake can cause hypertension in people suffering from sodium dysregulation

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News